Log in

Relevant bibliographies by topics / Ticarcilline

Contents

Journal articles
Dissertations / Theses
Book chapters

Academic literature on the topic 'Ticarcilline'

Author: Grafiati

Published: 4 June 2021

Last updated: 11 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Ticarcilline.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Ticarcilline"

1

Buxeraud, Jacques, and Alexis Skrzypek. "Ticarpen® - ticarcilline." Actualités Pharmaceutiques 47, no. 474 (2008): 55–57. http://dx.doi.org/10.1016/s0515-3700(08)70224-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Berche, P., and C. Offredo. "Efficacite in vivo de ticarcilline, ticarcilline-acide clavulanique et piperacilline au cours d'une infection experimentale par deux souches de E. cloacae." Médecine et Maladies Infectieuses 18 (September 1988): 59–62. http://dx.doi.org/10.1016/s0399-077x(88)80349-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Kabbaj, Hakima, Myriam Seffar, Bouchra Belefquih та ін. "Prevalence of Metallo-β-Lactamases Producing Acinetobacter baumannii in a Moroccan Hospital". ISRN Infectious Diseases 2013 (3 грудня 2013): 1–3. http://dx.doi.org/10.5402/2013/154921.

Full text

Abstract:

Objective. To determine the prevalence of metallo beta-lactamases (MBL) among carbapenem resistant strains of Acinetobacter baumannii in our hospital. Methodology. During a period of 12 months (January–December 2010), 47 isolates of Acinetobacter baumannii were collected from different clinical specimens of in-patients. Antimicrobial susceptibility was determined and interpreted using the disk diffusion method according to the Antibiogram Committee of the French Society for Microbiology guidelines. Imipenem nonsusceptible isolates were further screened for production of MBL. Results. All Acine

APA, Harvard, Vancouver, ISO, and other styles

4

Olivier, Galvez, Mullot Jean-Ulrich, Mullot Hélène, et al. "Étude de stabilité d’un collyre à 6 mg/mL de ticarcilline." Le Pharmacien Hospitalier 42, no. 171 (2007): 171–76. http://dx.doi.org/10.1016/s0768-9179(07)78193-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Miquel, M., D. Blaise, C. Fauchet, and D. Maraninchi. "Infection chez le neutropénique profond. Utilisation de l'association ticarcilline-acide clavulanique." Médecine et Maladies Infectieuses 23 (October 1993): 61–66. http://dx.doi.org/10.1016/s0399-077x(05)80516-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Muhammad Iqbal Khan, Riffat Arbab., Abdullah Khan, et al. "COMMONLY ISOLATED ORGANISM IN DIABETIC FOOT AND ITS ANTIBIOTIC SENSITIVITY, AN EXPERIENCE AT TERTIARY CARE HOSPITAL." Journal of University Medical & Dental College 11, no. 1 (2020): 23–30. http://dx.doi.org/10.37723/jumdc.v11i1.310.

Full text

Abstract:

Abstract BACKGROUND & OBJECTIVE: To determine the commonly isolated organism in ulcers of diabetic foot and its sensitivity to antibiotics. METHODOLOGY: A total of 167 patients of diabetic foot were included in this descriptive Crosssectional study. All the patients were informed and consent was obtained according to ethical criteria approved by the ethical committee. The use of antibiotics in last 72 hours was strictly observed. The samples were obtained under aseptic conditions by applying the swap slightly to the exudate or base of the ulcer and were then carefully transferr

APA, Harvard, Vancouver, ISO, and other styles

7

Brogard, J. M., F. Jehl, J. F. Blickle, M. Dorner, and H. Monteil. "Elimination et disposition hepatique de la ticarcilline et de l'acide clavulanique etude expérimentale." Médecine et Maladies Infectieuses 18, no. 10 (1988): 452–57. http://dx.doi.org/10.1016/s0399-077x(88)80233-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Chastagner, P., L. Mougel, A. Lozniewski, et al. "Traitement des épisodes fébriles chez les enfants neutropéniques par l'association ticarcilline-acide clavulanique et nétilmicine." Médecine et Maladies Infectieuses 27, no. 3 (1997): 301–5. http://dx.doi.org/10.1016/s0399-077x(97)80170-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Laporte, J. P., A. Verny, N. C. Gorin, A. Najman, and G. Duhamel. "Traitement par ticarcilline-acide clavulanique (TIC-CLA) et amikacine (AMK) utilisés en premiere intention en hématologie." Médecine et Maladies Infectieuses 15, no. 5 (1985): 301. http://dx.doi.org/10.1016/s0399-077x(85)80132-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Herbrecht, R., Y. Piemont, J. P. Bergerat, et al. "Etude de l'Association ticarcilline/acide clavulanique plus netilmicine dans le traitement des infections chez les patients neutropeniques." Médecine et Maladies Infectieuses 17, no. 3 (1987): 117–20. http://dx.doi.org/10.1016/s0399-077x(87)80341-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Ticarcilline"

1

MENAULT, PASCAL. "Etude critique d'une methode de dosage des antibiotiques au niveau alveolaire : application a la ticarcilline." Lyon 1, 1989. http://www.theses.fr/1989LYO1M472.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

HESCHUNG, BANON VERONIQUE. "Interet de l'association ticarcilline-acide clavulanique dans le traitement des infections des maladies neutropeniques." Strasbourg 1, 1989. http://www.theses.fr/1989STR15066.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

GARDIEN, ERIC. "Etude de l'activite bactericide de l'association piperacilline + tazobactam comparee a celle de l'amoxicilline + acide clavulanique et de la ticarcilline + acide clavulanique sur differents phenotypes d'escherichia coli." Nantes, 1994. http://www.theses.fr/1994NANT218M.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Granier, Bernard. "Activité des associations ticarcilline-acide clavulanique et piperacilline-tazobactam sur les enterobactéries, "Pseudomonas aeruginosa" et les "Acinetobacter baumanii"." Paris 5, 1994. http://www.theses.fr/1994PA05P196.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Watson, I. D. "The assay and pharmacokinetics of some chemotherapeutic agents : An investigation of the kinetics of co-trifamole, co-trimoxazole, trimethoprim alone and clavulanate potentiated ticarcillin with consideration of the prediction of plasma drug concentration." Thesis, University of Glasgow, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.374548.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

CHEN, PENG-YING, and 陳芃穎. "The impacts of L1 and L2 B-lactmase on ticarcillin-clavulanate susceptibility of Stenotrophomonas maltophilia." Thesis, 2018. http://ndltd.ncl.edu.tw/handle/cf2afw.

Full text

Abstract:

碩士<br>國立陽明大學<br>醫學生物技術暨檢驗學系<br>106<br>Stenotrophomonas maltophilia, a species of highly genetic diversity, is an important nosocomial pathogen. Inducible expression of the chromosomally encoded L1 and L2 B-lactamases is the principal mechanism responsible for B-lactam resistance in S. maltophilia. L1 and L2 belong to Amber Class B and Class A B-lactamases, respectively. Ticarcillin-clavulanate (TIM) is one of the few effective B-lactam for S. maltophilia treatment. Clavulanate (CA) is a B-lactamase inhibitor which specifically inhibits the activities of Class A, C, and D B-lactamases. In view

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Ticarcilline"

1

Barry, Arthur L. "Prevalence of Ticarcillin/Clavulanic Acid-Resistant Enterobacteriacaeae in Nine Separate Medical Centers During the Years 1983, 1989, and 1991." In Advances in Experimental Medicine and Biology. Springer US, 1994. http://dx.doi.org/10.1007/978-1-4757-9206-5_17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Chevrel, Guillaume, and Virginie Dessus. "ticarcilline." In 300 médicaments injectables. Elsevier, 2009. http://dx.doi.org/10.1016/b978-2-294-70698-1.50162-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Chevrel, Guillaume, and Virginie Dessus. "ticarcilline/acide clavulanique." In 300 médicaments injectables. Elsevier, 2009. http://dx.doi.org/10.1016/b978-2-294-70698-1.50163-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Castle, Sharon S. "Ticarcillin." In xPharm: The Comprehensive Pharmacology Reference. Elsevier, 2007. http://dx.doi.org/10.1016/b978-008055232-3.62763-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

"TICARCILLIN." In Litt's Drug Eruption Reference Manual Including Drug Interactions. CRC Press, 2004. http://dx.doi.org/10.3109/9780203492079-177.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Papich, Mark G. "Ticarcillin Disodium." In Saunders Handbook of Veterinary Drugs. Elsevier, 2016. http://dx.doi.org/10.1016/b978-0-323-24485-5.00553-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Papich, Mark G. "Ticarcillin Disodium." In Papich Handbook of Veterinary Drugs. Elsevier, 2021. http://dx.doi.org/10.1016/b978-0-323-70957-6.00531-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Buising, Kirsty. "Ticarcillin–Clavulanic Acid." In Kucers' The Use of Antibiotics Sixth Edition. CRC Press, 2010. http://dx.doi.org/10.1201/b13787-20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Papich, Mark G. "Ticarcillin + Clavulanate Potassium." In Saunders Handbook of Veterinary Drugs. Elsevier, 2016. http://dx.doi.org/10.1016/b978-0-323-24485-5.00554-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

"Ticarcillin Disodium–Clavulanate Potassium." In Pediatric Injectable Drugs. American Society of Health-System Pharmacists, 2018. http://dx.doi.org/10.37573/9781585285402.228.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!